2030 Compounding Vaccines 
European Pharmaceutical Review
NOVEMBER 7, 2024
A report by Azoth Analytics expects that globally, the single-use technology rocking bioreactors market will grow at a compound annual growth rate (CAGR) of 3.9 percent between 2025 and 2030. The report noted that last year, the cell culture sector held approximately 60 percent of the single-use technology rocking bioreactors market.
Express Pharma
DECEMBER 8, 2023
The 12 blockbuster drugs include nine medicines and vaccines with 2 billion to 5 euros ($2.15-$5.38 The 12 blockbuster drugs include nine medicines and vaccines with 2 billion to 5 euros ($2.15-$5.38 billion) of annual sales by 2030.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JUNE 27, 2022
The Kigali Summit on Malaria and NTDs , hosted by His Excellency (HE) Paul Kagame, President of the Republic of Rwanda, on Thursday 23 June 2022, gathered world leaders to commit to ending these devastating diseases by the end of 2030. Did you know, 1.7 LXE408 is currently entering Phase II clinical development.
Pharmaceutical Technology
MAY 18, 2023
The World Health Organization (WHO) 2021 roadmap outlines plans to eradicate 20 listed diseases, which include leprosy, scabies and mycetoma, by 2030. Neglected tropical diseases are a major global health concern, affecting over 1.7 billion people, many of whom live in the poorest and most vulnerable communities.
Express Pharma
NOVEMBER 28, 2023
Over-the-counter accessibility and limited awareness compound the problem. Dr Ranga Reddy, President, Infection Control Academy of India said, “AMR poses a threat to various aspects of life, undermining the 2030 Sustainable Development Goals, especially in regions with inadequate sanitation.
Express Pharma
JULY 10, 2024
India has traced a journey of grit and glory to emerge as a major supplier of generic drugs and vaccines globally. Brimming with potential As per an Invest India report of 2023, the Indian Bioeconomy, valued at $137 billion in 2023, is targeted to reach $150 billion by 2025 and $300 billion by 2030. million and contributes around $1.4
Express Pharma
MAY 25, 2024
India’s pharmaceutical industry is on a promising path, with a vision to reach a staggering $130 billion by 2030 and $450 billion by 2047, according to a report by Ernst and Young. This growth is fueled by a thriving pharma industry that has already exported over 300 million vaccine doses as of July 2023 and impressive growth with $668.9
Expert insights. Personalized for you.
52 
Let's personalize your content